Here is a quick summary of the third quarter financial results for all the companies announced till date. For some companies, management comments have been ...
As part of our year-end piece, we look at the Top 10 Large-cap performers for 2016 (ending 23-Dec). You can catch our earlier series here: 2015 in Review: ...
Biocon – one of the largest emerging global biopharmaceutical enterprise (has a rich pipeline of Biosimilars and Novel Biologics at various stages of ...
Q4 Results are out! As the companies line up to disclose their performance report, we bring you a daily summary of the previous days results. Here is a quick ...
Biocon has been rumoured to have serious developments in its oral insulin product, and in talks with a few large pharma companies to license the product. This ...
